Post Date December, 02 2023
Prostate disease is a common disease in men, which has the characteristics of many diseases, high incidence rate and long onset years, and has a trend of increasing year by year. Prostatitis can occur at any time in adolescence, adulthood, and old age. According to some data, prostatitis accounts for 60 to 70% of the incidence in urology, especially in males over 35 years old, which accounts for 35 to 40%; In addition, according to the statistics of medical authorities, the incidence rate of prostatic hyperplasia in middle-aged people is about 40%, while the incidence rate of the elderly is as high as more than 70%. For a long time, discomfort caused by prostate hyperplasia has been troubling men.
The so-called proliferation refers to the increase in the volume of tissues and organs caused by the increase in the number of parenchymal cells, which is the result of increased mitotic activity of cells caused by various reasons. The human prostate is no exception. From birth to pre puberty, the development and growth of the prostate are slow; After puberty, the growth rate accelerates and reaches its peak around the age of 24. Its volume is relatively stable between 30 and 45 years old. Later, some people tend to atrophy and the gland volume decreases, while others tend to proliferate. The gland volume gradually increases. If the prostate urethra is significantly compressed, it can cause bladder outlet obstruction and related symptoms of difficulty urinating, namely prostate hyperplasia. Due to its benign nature, this type of hyperplasia is called benign prostatic hyperplasia, formerly known as prostate enlargement.
Prostate hyperplasia is a common disease in elderly men, and usually begins to undergo pathological changes of hyperplasia after the age of 40, with related symptoms appearing after the age of 50. At present, some people believe that the combination of estrogen and androgen in prostate tissue can stimulate the synthesis and secretion of extracellular matrix proteins by cells, forming a dense layer of fibrous connective tissue around the cells, thereby participating in the occurrence and development of prostate hyperplasia. That is, there is a synergistic effect between estrogen and androgen in the occurrence and development of prostate hyperplasia, and the change in the balance between estrogen and androgen is the reason for the occurrence of prostate hyperplasia. As men age, the secretion of androgens gradually decreases, leading to an imbalance in sexual arousal in the body and ultimately leading to prostate hyperplasia.
The proposal of new basic theories has pointed out a new direction for us to treat prostate hyperplasia - by regulating the body's endocrine system, controlling hormone levels in the body, and reducing the triggers of prostate hyperplasia. Traditional Chinese medicine (TCM) has always emphasized conditioning, with the emphasis on "essence", "qi", and "spirit" in TCM theory corresponding to the endocrine system, immune system, and nervous system of Western medicine. Traditional Chinese medicine refined decoction can regulate the endocrine system, balance hormone levels in the body, slow down sexual organ aging, and play an effective auxiliary role in the treatment of prostate hyperplasia by regulating the hypothalamus pituitary thymus gonad system.
